Rivaroxaban Sandoz vascular 2

Rivaroxaban Sandoz vascular 2 is a medicine authorised by Swissmedic under authorisation number 68804. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 October 2022 and the authorisation is limited until 09 October 2027. ATC code B01AF01 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 68804
  • ATC B01AF01
  • Synthetic medicines
Authorisation data
Authorisation number68804
NameRivaroxaban Sandoz vascular 2
Full nameRivaroxaban Sandoz vascular 2,5 mg, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AF01
First authorisation10 October 2022
Authorisation validity09 October 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Rivaroxaban Sandoz vascular 2,5 mg, FilmtablettenB10 October 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)B01AF0106.03.0.B
230Tablette(n)B01AF0106.03.0.B
356Tablette(n)B01AF0106.03.0.B
4100Tablette(n)B01AF0106.03.0.B
5196Tablette(n)B01AF0106.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivaroxaban Sandoz vascular 2 authorised in Switzerland?

Yes. Rivaroxaban Sandoz vascular 2 is authorised by Swissmedic under authorisation number 68804, data as of 01 September 2026. The authorisation is limited until 09 October 2027.

Which dispensing category does Rivaroxaban Sandoz vascular 2 have?

Rivaroxaban Sandoz vascular 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivaroxaban Sandoz vascular 2?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com